To maximize the likelihood of observing differences between AD and control, we selected only AD specimens with high scores for amyloid and tau neuropathology in frontal cortex, and we selected only control specimens with negligible amounts of these pathologies in this region (see sample metadata in Data S2). Here, MAPT is linked to Alzheimer disease.